Amplitude Surgical: Q1 2016-17 Sales of €17.3 Million, up 23.2% in Actual Terms and 21.4% at Constant Currency

Regulatory News:

Amplitude Surgical (Paris:AMPLI) (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible), a leading French player on the global surgical technology market for lower-limb orthopedics, today announces its sales for the first quarter of its 2016-17 financial year.

Olivier Jallabert, Chairman and CEO of Amplitude Surgical, says: "The buoyant growth in activity, only organic, recorded over the first quarter of this financial year is in line with that recorded in previous quarters. In particular, Novastep, our innovative solutions for extremities surgery, has seen sales virtually double and now accounts for almost 8% of our total sales. The confirmation of the success of our new products and the expected developments on major markets will help us continue recording further buoyant growth, the aim being to double our sales in five years, and to win further market share.”

In the first quarter (July to September) of its 2016-17 financial year, Amplitude Surgical recorded sales of €17.3 million, up +23.2% in actual terms and +21.4% at constant currency.

On the French market, Amplitude Surgical is continuing to win over new clients and increase its market share. In the first quarter, French sales totaled €10.1 million, up +20.4%.

The growth in international sales over the first quarter, +22.9% at constant currency, came from both the Group’s subsidiaries, +18.9% at constant currency, which accounted for over 80% of international activity, and its distributors, +42.6% at constant currency. The first quarter saw a continuation of the very strong sales dynamic in Benelux and a good performance by the Group’s new subsidiaries in South Africa and Japan, which generated quarterly sales of over €180 thousand.

In their third year of marketing, Novastep’s innovative solutions for extremities (foot and ankle) surgery continued to record very buoyant growth. Sales totaled €1.2 million over the quarter, or nearly 8% of Group sales, almost double (+94% at constant currency) the figure for the same quarter of 2015-16. This increase was substantial on all markets, including France, which accounts for over 30% of activity, where sales increased by more than 70%, and the United States, which accounts for almost 40% of activity, where sales increased almost threefold.

Next financial press release: H1 2016-17 sales, Wednesday February 15, 2017, after market.

About Amplitude Surgical

Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player on the global surgical technology market for lower-limb orthopedics. Amplitude Surgical develops and markets high-end products for orthopedic surgery covering the main disorders affecting the hip, knee and extremities, and notably foot and ankle surgery. Amplitude Surgical develops, in close collaboration with surgeons, numerous high value-added innovations in order to best meet the needs of patients, surgeons and healthcare facilities. A leading player in France, Amplitude Surgical is developing abroad through its subsidiaries and a network of exclusive distributors and agents. Amplitude Surgical operates on the lower-limb market through the intermediary of its Novastep subsidiaries in France and the United States. Amplitude Surgical distributes its products in more than 30 countries. At June 30, 2016, Amplitude Surgical had a workforce of almost 300 employees and recorded sales of over 80 million euros.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161123005346/en/